- Home
- FULC vs SRTA Comparison
FULC vs SRTA Comparison
Compare FULC & SRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- SRTA
- Stock Information
- Founded
- FULC 2015
- SRTA 2014
- Country
- FULC United States
- SRTA United States
- Employees
- FULC N/A
- SRTA N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- SRTA
- Sector
- FULC Health Care
- SRTA
- Exchange
- FULC Nasdaq
- SRTA Nasdaq
- Market Cap
- FULC 469.0M
- SRTA 438.4M
- IPO Year
- FULC 2019
- SRTA N/A
- Fundamental
- Price
- FULC $8.73
- SRTA $4.93
- Analyst Decision
- FULC Buy
- SRTA Strong Buy
- Analyst Count
- FULC 6
- SRTA 1
- Target Price
- FULC $8.67
- SRTA $7.25
- AVG Volume (30 Days)
- FULC 524.6K
- SRTA 996.5K
- Earning Date
- FULC 11-12-2025
- SRTA 11-10-2025
- Dividend Yield
- FULC N/A
- SRTA N/A
- EPS Growth
- FULC N/A
- SRTA N/A
- EPS
- FULC N/A
- SRTA N/A
- Revenue
- FULC N/A
- SRTA $254,341,000.00
- Revenue This Year
- FULC N/A
- SRTA N/A
- Revenue Next Year
- FULC N/A
- SRTA $28.16
- P/E Ratio
- FULC N/A
- SRTA N/A
- Revenue Growth
- FULC 2752.05
- SRTA 6.70
- 52 Week Low
- FULC $2.32
- SRTA $3.85
- 52 Week High
- FULC $9.88
- SRTA $6.02
- Technical
- Relative Strength Index (RSI)
- FULC 54.66
- SRTA N/A
- Support Level
- FULC $9.10
- SRTA N/A
- Resistance Level
- FULC $9.88
- SRTA N/A
- Average True Range (ATR)
- FULC 0.57
- SRTA 0.00
- MACD
- FULC -0.02
- SRTA 0.00
- Stochastic Oscillator
- FULC 56.24
- SRTA 0.00
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About SRTA Strata Critical Medical Inc. Class A Common Stock
Strata Critical Medical Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs.